Overview

An Evaluation of the Efficacy and Safety of CSF-1 in the Temporary Correction of Presbyopia (NEAR-2)

Status:
Recruiting
Trial end date:
2021-12-14
Target enrollment:
0
Participant gender:
All
Summary
This is a 4-visit, multi-center, randomized, double-masked, vehicle-controlled study evaluating the safety and efficacy of CSF-1 in the temporary correction of presbyopia.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Orasis Pharmaceuticals Ltd.
Criteria
Inclusion Criteria:

- Subjects must have presbyopia.

Exclusion Criteria:

Subjects must not:

- Have any contraindications to the study medications or diagnoses that would confound
the study.